CORT Q1 2023 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$106M+12.8% YoY

Gross Profit

$104M98.7% margin

Operating Income

$15M14.1% margin

Net Income

$16M15.0% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

+2.5%

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$26M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$618M

Total Liabilities

$88M

Stockholders' Equity

$530M

Cash & Equivalents

$300M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$106M	$94M	+12.8%
Gross Profit	$104M	$92M	+12.8%
Operating Income	$15M	$27M	-44.5%
Net Income	$16M	$23M	-30.3%